Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapiglutide for Obesity (DREAM)
NCT05788601Phase 2Active, not recruiting
- Sponsor
- Gentofte Hospital
- Start
- Apr 2023
- Primary completion
- Apr 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of dapiglutide in obesity, sponsored by Gentofte Hospital. Started Apr 2023; status: active, not recruiting.
02
Drugs
dapiglutide
03
Conditions
obesity
Beyond the preview
Go deeper on NCT05788601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05788601.